← All organizations

Scioderm, Inc.

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

May 1, 2015

Acquired by Amicus Therapeutics → Biomarin on Aug 31, 2015

Timeline

2010s

Jun 1, 2012
Scioderm, Inc.— Founded
Aug 31, 2015
Amicus Therapeutics— Acquired By

2020s

Dec 19, 2025
Biomarin— Now

Drugs by trial phase (2 distinct, 4 trials)

Phase 3 (1 own, 0 via acquisition)

sd-101

Other trials (1 own, 0 via acquisition)

zorblisa

Indications

Studied for

Epidermolysis Bullosa

Recent trials (4)

NCT02670330Lead sponsorN/AMay 1, 2015
NCT02384460Lead sponsorPhase 3Mar 1, 2015
NCT02090283Lead sponsorN/AMar 1, 2014
NCT02014376Lead sponsorPhase 2Jan 1, 2014

Details

Founded: Durham, NC, US Jun 1, 2012
Last known activity: May 1, 2015